THE DEFENSE ALWAYS HAS A THEORY.

IT’S NOT TRUMP’S FAULT

Antidepressant escitalopram more effective at preventing relapse, analysis finds

VOTING CLOSED

Voting on: Antidepressant escitalopram more effective at preventing relapse, analysis finds

Poll

All Responses

Hung jury.

Yes, it's Trump's fault

0%

No, it's not Trump's fault

0%

Too soon to tell

0%

0 verified votes

Yes, it's Trump's fault

The prosecution's case: Antidepressant escitalopram more effective at preventing relapse, analysis finds

The extreme prosecution of the sourced event.

No, it's not Trump's fault

The defense's case: Antidepressant escitalopram more effective at preventing relapse, analysis finds

The extreme defense of the sourced event.

A courtroom excuse or victory lap pushed to the extreme, using the same factual record.

Real event · international · 2026-11-11

The defense's case: Antidepressant escitalopram more effective at preventing relapse, analysis finds

Final verdict announced: November 12, 2026 at 5:01 AM ET

Satire

The extreme defense of the sourced event.

What actually happened

Real headline

Antidepressant escitalopram more effective at preventing relapse, analysis finds

Three pills came top and outperformed Prozac for preventing relapse in a large number of patients.

Who took the documented action

See the original report.

Original reporting

Sources

What the record shows

Three pills came top and outperformed Prozac for preventing relapse.

The extreme defense

The Result

The defense might argue: Ladies and gentlemen of the jury, the recent analysis showing escitalopram's effectiveness in preventing relapse is a monumental victory for mental health treatment. The defense submits that this breakthrough offers hope to countless individuals struggling with depression.

What Trump Did

The defense might argue that the focus on mental health during Trump's administration laid the groundwork for these advancements.

Why Supporters Credit Him

Supporters might argue that this analysis reflects a broader trend of improving mental health care, which began during Trump's term. The defense admits that while Trump may not have directly influenced this specific study, his policies contributed to a more open dialogue about mental health.

The Supporting Record

The defense might suggest that the rise of escitalopram and its effectiveness is a testament to the ongoing evolution of antidepressants, showcasing the importance of continued research and development.

The Limitation or Competing Explanation

However, the defense might argue that while escitalopram is effective, it is essential to recognize that many factors contribute to mental health outcomes, including societal changes and increased awareness.

Verdict

If this is Trump's fault, his supporters will gladly let him take the blame.

Defense exhibits

  1. Supporters' theory: Escitalopram's rise is a victory for mental health treatment.
  2. Supporters' theory: Trump's focus on healthcare opened doors for advancements.
  3. Supporters' theory: This analysis reflects a broader trend of improving mental health care.

Reality Check

Three pills came top and outperformed Prozac for preventing relapse in a large number of patients.

Satirical commentary based on the sourced facts above. Not a news report, campaign, or endorsement.

See the opposite spin

Hub facts Somehow spin Not spin Compare both spins

Previous · Next · Archive · Canonical: /not/stories/antidepressant-escitalopram-more-effective-at-preventing-relapse-analysi-ignrss